aTyr Pharma, Inc. (NASDAQ:ATYR) People

aTyr Pharma, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kathryn Falberg
Other companies: Nuvation Bio Inc. (Board of Directors · Since at least Feb 10, 2021); Arcus Biosciences, Inc. (Board Member · Since at least Mar 14, 2018); The Trade Desk, Inc. (Director · Since at least Sep 20, 2016); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Jun 7, 2021 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Sio Gene Therapies Inc (Director · Apr 7, 2017 – May 15, 2017 · Past); BioMarin Pharmaceutical Inc. (Director · Jul 15, 2016 – Jul 15, 2016 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); Medivation Inc (Director · Jan 31, 2013 – Sep 28, 2016 · Past); Jazz Pharmaceuticals plc (EVP and CFO · Dec 1, 2009 – Mar 5, 2014 · Past); Novelion Therapeutics Inc (Director · Mar 25, 2009 – May 26, 2011 · Past); Oruka Therapeutics, Inc. (CFO and COO · Feb 23, 2009 – Jun 25, 2009 · Past); Halozyme Therapeutics, Inc. (Director · May 15, 2007 – May 4, 2016 · Past)
Director · May 6, 2015 – May 24, 2016 · Past
Jeffrey S. Hatfield
Other companies: Vir Biotechnology, Inc. (Chair of the Board · Since at least Dec 9, 2020); Larimar Therapeutics, Inc. (Chief Executive Officer, Director · Oct 9, 2017 – Jan 22, 2019 · Past); Viridian Therapeutics, Inc. (Director · Aug 10, 2017 – Feb 4, 2021 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 1, 2016 – Jan 19, 2018 · Past); Vitae Pharmaceuticals Inc (Chief Executive Officer, Director · Sep 24, 2014 – Oct 24, 2016 · Past); Ambit Biosciences Corp (Director · Jun 2, 2014 – Nov 10, 2014 · Past)
Director · Apr 3, 2017 – May 6, 2020 · Past
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · May 6, 2015 – May 9, 2017 · Past
Paul Schimmel
Other companies: Alnylam Pharmaceuticals, Inc. (Co-founder and member of the Board of Directors · Since at least Jan 31, 2006); Tocagen Inc (Director · Apr 12, 2017 – Oct 4, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – Nov 30, 2007 · Past); Repligen Corporation (Director · Aug 11, 2006 – Jun 14, 2007 · Past); Alkermes plc (Director · Mar 2, 2006 – Jun 15, 2007 · Past)
Director · Since at least May 6, 2015
Timothy P. Coughlin
Other companies: Vir Biotechnology, Inc. (Director · Since Jun 9, 2026); ADC Therapeutics SA (Director · Since at least Jun 3, 2025); Travere Therapeutics, Inc. (Director · Since at least Mar 31, 2015); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Jun 7, 2024 · Past); Neurocrine Biosciences, Inc. (Chief Financial Officer · Sep 18, 2006 – Feb 6, 2017 · Past)
Chairman · Since at least Apr 7, 2017
Jill Marie Broadfoot
Other companies: Cue Biopharma, Inc. (Director · Since at least Jun 4, 2025); Talphera, Inc. (Director · Since at least Nov 20, 2021); Otonomy Inc (Director · Aug 18, 2021 – Jun 21, 2022 · Past); Vical Incorporated (Sr Vice President, CFO, Sec · Jan 7, 2011 – Apr 1, 2013 · Past)
Chief Financial Officer · Since at least Jul 30, 2018
John Mendlein
Other companies: Fate Therapeutics, Inc. (Director · Since at least Sep 30, 2013); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 20, 2024 · Past); Moderna, Inc. (See Remarks · Dec 7, 2018 – Dec 7, 2018 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past)
Director · May 6, 2015 – May 8, 2019 · Past
Svetlana Lucas
Other companies: Scribe Therapeutics Inc. (Chief Business Officer · Since at least Mar 13, 2026); Jasper Therapeutics, Inc. (Board Member · Since at least Jun 18, 2024)
Director · Since at least Jun 28, 2019
Eric Benevich
Other companies: Neurocrine Biosciences, Inc. (Chief Commercial Officer · Since at least May 26, 2015)
Director · Since at least Dec 10, 2024
Andrew CubittVP, Product Protection · May 6, 2015 – Sep 13, 2016 · Past
Ashlee DunstonInvestor Relations and Public Affairs · Since at least Oct 29, 2026
Brandon YarasChief Financial Officer · Since at least Aug 10, 2026
Danielle CampbellVP, Human Resources · Since at least Nov 5, 2026
Fred RamsdellVP, Immunology · May 6, 2015 – Oct 1, 2015 · Past
Jane A. GrossDirector · Since at least Nov 5, 2026
Leslie NangleVP, Research · Since at least Oct 13, 2026
Lisa CareyVP, Clinical Operations · Since at least Sep 30, 2025
Nancy DenyesGeneral Counsel · Since at least Jan 5, 2024
Sanjay S. ShuklaPresident and CEO, Director · Since at least Mar 30, 2016
Sara L. ZaknoenDirector · Since at least May 21, 2021
Stan BlackburnActing Chief Financial Officer · May 6, 2015 – Jan 27, 2016 · Past